ConcertAI is a life sciences and healthcare technology leader specializing in generative and agentic AI solutions that integrate real-world data to accelerate clinical research, oncology trials, and patient outcomes. The company offers an integrated suite of products, including Precision Explorer, Precision Trials, and CancerLinQ, designed to generate actionable insights across regulatory, research, and commercial domains. With a global focus on oncology and translational medicine, ConcertAI combines real-world evidence, clinical expertise, and AI-driven analytics to de-risk trial design, optimize trial operations, and improve patient care. Through its partnerships and portfolio, the company aims to unify data and analytics across discovery, development, and delivery in life sciences and healthcare.
No recent deals for this company.